Form 4: BioAtla CMO Eric Sievers Reports Tax Withholding

BioAtla's Chief Medical Officer, Eric Sievers, reported a tax-related disposition of 3,140 common shares following the vesting of restricted stock units.

Summary

• Eric Sievers, Chief Medical Officer of BioAtla, Inc. (BCAB), reported a transaction on February 28, 2026.
• 3,140 shares of BioAtla common stock were disposed of at a price of $0.247 per share.
• This disposition was not a sale by Mr. Sievers but represents shares withheld by BioAtla to satisfy income tax and withholding obligations.
• The withholding was in connection with the vesting and net settlement of previously reported restricted stock units.
• Following this transaction, Eric Sievers beneficially owns 358,705 shares of BioAtla common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine, non-discretionary transaction related to executive compensation and tax obligations, thus having a neutral impact on company sentiment.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency on executive holdings rather than strategic industry shifts. This particular filing details a routine tax-related event common with executive compensation plans involving restricted stock units.

Stakeholder Impact

• Shareholders gain transparency regarding executive stock ownership and compensation-related transactions.

Key Dates

Recommendation

This Form 4 reports a routine tax-related disposition of shares following RSU vesting, which is a common and expected event for executive compensation. It does not indicate any discretionary selling or provide new information that would alter the investment thesis for BioAtla, Inc.

Keywords

BioAtla, BCAB, Form 4, insider transaction, Eric Sievers, Chief Medical Officer, common stock, restricted stock units, RSU, tax withholding